1. Cardiovascular and pulmonary adverse events in patients treated with BCR‐ABL inhibitors: Data from the FDA Adverse Event Reporting System. Issue 4 (30th January 2015) Authors: Cortes, Jorge; Mauro, Michael; Steegmann, Juan Luis; Saglio, Giuseppe; Malhotra, Rachpal; Ukropec, Jon A.; Wallis, Nicola T. Journal: American journal of hematology Issue: Volume 90:Issue 4(2015:Apr.) Page Start: E66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗